Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy

Por Zhang, Hongyu, Saha, Jharna, Byun, Jaeman, Schin, MaryLee, Lorenz, Matthew, Kennedy, Robert T., Kretzler, Matthias, Feldman, Eva L., Pennathur, Subramaniam, Brosius, Frank C.
Publicado em 2008

Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice

Por Blauwkamp, Marsha N, Yu, Jingcheng, Schin, MaryLee A, Burke, Kathleen A, Berry, Marla J, Carlson, Bradley A, Brosius, Frank C, Koenig, Ronald J
Publicado em 2008

Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice

Por Zhang, Hongyu, Schin, MaryLee, Saha, Jharna, Burke, Kathleen, Holzman, Lawrence B., Filipiak, Wanda, Saunders, Thomas, Xiang, Minghui, Heilig, Charles W., Brosius, Frank C.
Publicado em 2010

Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy

Por Berthier, Celine C., Zhang, Hongyu, Schin, MaryLee, Henger, Anna, Nelson, Robert G., Yee, Berne, Boucherot, Anissa, Neusser, Matthias A., Cohen, Clemens D., Carter-Su, Christin, Argetsinger, Lawrence S., Rastaldi, Maria P., Brosius, Frank C., Kretzler, Matthias
Publicado em 2009